Our recognition
Latest stories
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
- Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes Press Release, Financial Results 26 February 2026 Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
- Hikma launches authorised generic of Nucynta® (tapentadol) in the US Press Release, Product 25 February 2026 Hikma launches authorised generic of Nucynta® (tapentadol) in the US
- Inspired at Hikma. Meet Ana Santos Perez Story, Life at Hikma 13 February 2026 Inspired at Hikma. Meet Ana Santos Perez
- Hikma R&D. Innovation in clinical research. Meet Hiba Kamal Story, Life at Hikma 11 February 2026 Hikma R&D. Innovation in clinical research. Meet Hiba Kamal
Related content